baclofen has been researched along with Deficiency, Mental in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "There are few reports of spasticity treatment for people with ID, and none of functionally meaningful outcomes." | 1.36 | Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability. ( Ayers, GD; Blair, CR; Charles, PD; Gill, CE; Konrad, PE; Putman, MS; Roberts, AG; Taylor, HM, 2010) |
| "During an outcomes study of spasticity treatment at a developmental center for 62 residents with profound intellectual disabilities, either botulinum toxin A (BTX-A), intrathecal baclofen (ITB), or both were recommended with physical and occupational therapy." | 1.36 | Discordance in informed consent response on the basis of demographic factors: brief report. ( Charles, PD; Gill, CE; Harrison, CH; Nunez-Wallace, KR; Taylor, HM, 2010) |
| "To ascertain the prevalence of spasticity among adults living in a developmental center and to document the development of spasticity treatment plans for this population." | 1.32 | Spasticity in adults living in a developmental center. ( Charles, PD; Damian, MM; Noel-Spaudling, S; Pfister, AA; Roberts, AG; Taylor, HM, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stoppel, LJ | 1 |
| Kazdoba, TM | 1 |
| Schaffler, MD | 1 |
| Preza, AR | 1 |
| Heynen, A | 1 |
| Crawley, JN | 1 |
| Bear, MF | 1 |
| Marvulli, R | 1 |
| Chiumarulo, P | 1 |
| Nisi, M | 1 |
| Barulli, L | 1 |
| Megna, G | 1 |
| Pietro, F | 1 |
| Ianieri, G | 1 |
| Megna, M | 1 |
| Charles, PD | 3 |
| Gill, CE | 2 |
| Taylor, HM | 3 |
| Putman, MS | 1 |
| Blair, CR | 1 |
| Roberts, AG | 2 |
| Ayers, GD | 1 |
| Konrad, PE | 1 |
| Nunez-Wallace, KR | 1 |
| Harrison, CH | 1 |
| Gandal, MJ | 1 |
| Sisti, J | 1 |
| Klook, K | 1 |
| Ortinski, PI | 1 |
| Leitman, V | 1 |
| Liang, Y | 1 |
| Thieu, T | 1 |
| Anderson, R | 1 |
| Pierce, RC | 1 |
| Jonak, G | 1 |
| Gur, RE | 1 |
| Carlson, G | 1 |
| Siegel, SJ | 1 |
| Pfister, AA | 1 |
| Noel-Spaudling, S | 1 |
| Damian, MM | 1 |
| Pirovino, M | 1 |
| Meier, J | 1 |
| Meyer, M | 1 |
| Waldmeier, P | 1 |
| Schmid, M | 1 |
| Primrose, DA | 1 |
| Yassa, R | 1 |
| Nair, V | 1 |
| Dimitry, R | 1 |
| Yamaguchi, S | 1 |
| Orii, T | 1 |
| Yasuda, K | 1 |
| Kohno, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Inter-Rater Reliability of a Spasticity Diagnosis Algorithm[NCT01644123] | 72 participants (Actual) | Observational | 2013-04-30 | Completed | |||
| Using Telemedicine to Improve Spasticity Diagnosis Rates[NCT03211390] | 60 participants (Actual) | Observational | 2018-01-30 | Completed | |||
| Prevalence of Comorbid Spasticity and Urinary Incontinence in Residents of a Long-Term Care Facility[NCT03250988] | 60 participants (Actual) | Observational | 2018-01-30 | Completed | |||
| Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity[NCT03209960] | 60 participants (Actual) | Observational | 2018-01-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for baclofen and Deficiency, Mental
| Article | Year |
|---|---|
Treatment of self-injurious behaviour with a GABA (gamma-aminobutyric acid) analogue.
Topics: Adolescent; Adult; Anorexia; Baclofen; Child; Clinical Trials as Topic; Double-Blind Method; Epileps | 1979 |
9 other studies available for baclofen and Deficiency, Mental
| Article | Year |
|---|---|
R-Baclofen Reverses Cognitive Deficits and Improves Social Interactions in Two Lines of 16p11.2 Deletion Mice.
Topics: Animals; Autistic Disorder; Baclofen; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, | 2018 |
Use Of External Intrathecal Infusion Pumps In The Management Of Septic Complications: A Case Report.
Topics: Abdomen; Administration, Oral; Adolescent; Anti-Bacterial Agents; Baclofen; Catheter-Related Infecti | 2015 |
Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2010 |
Discordance in informed consent response on the basis of demographic factors: brief report.
Topics: Baclofen; Black or African American; Botulinum Toxins, Type A; Caregivers; Female; Humans; Informed | 2010 |
GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.
Topics: Animals; Autistic Disorder; Baclofen; Disease Models, Animal; Evoked Potentials, Auditory; Explorato | 2012 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
Spasticity in adults living in a developmental center.
Topics: Activities of Daily Living; Adult; Aged; Baclofen; Botulinum Toxins, Type A; Cerebral Palsy; Comorbi | 2003 |
[Malignant neuroleptics syndrome].
Topics: Adult; Amantadine; Baclofen; Cerebrospinal Fluid; Chromatography, Liquid; Cognition Disorders; Femal | 1984 |
Prevalence of tardive dystonia.
Topics: Adult; Aged; Antipsychotic Agents; Baclofen; Cross-Sectional Studies; Dementia; Drug Therapy, Combin | 1986 |
A case of glutaric aciduria type I with unique abnormalities in the cerebral CT findings.
Topics: Baclofen; Female; gamma-Aminobutyric Acid; Gas Chromatography-Mass Spectrometry; Glutarates; Glutary | 1987 |